«Where Healthcare Innovation Meets Capital Markets»
The first HealthCare Investors Meeting (HCIM) with over 100 participants was successfully held at the Genolier Innovation Hub on 31st March 2026.
The conference will brought together investors, analysts, and representatives of leading Swiss-listed small and medium-sized enterprises (SMEs) from the medtech and pharmaceutical sectors. The aim of the meeting is to strengthen the dialogue between the capital markets and innovative healthcare companies.
The next HCIM will take place on
13th april 2027 in Genolier.
You can download the presentations here:
AEVIS Victoria – Fabrice Zumbrunnen (CEO) & Michel Keusch (CFO)
Galenica – Julian Fiessinger (CFO)
Polypeptide – Juan José Gonzalez (CEO)
Basilea – David Veitch (CEO) & Adesh Kaul (CFO)
Medacta – Francesco Siccardi (CEO)
BioVersys – Hernán Levett (CFO)
Cutiss – Daniela Marino (CEO)
OM Pharma – Roch Ogier (CEO)
Topadur Pharma – Dr. Reto Naef (Founder & President)
AB2Bio – Djordje Filipovic (CEO)
AGEFI Be to B
Press release (pdf) english / german.
